Verano Holdings (VRNO) Non-Current Assets (2021 - 2026)

Verano Holdings' (VRNO) quarterly Non-Current Assets came in at $29.0 million in Q1 2026, down 0.65% year-on-year from $29.2 million in Q1 2025, and down 2.63% on a QoQ basis from $29.8 million in Q4 2025.

Verano Holdings (VRNO) Non-Current Assets (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Non-Current Assets data on file, last reported at $29.0 million in Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 0.65% year-over-year to $29.0 million in Q1 2026; TTM through Mar 2026 was $29.0 million, a 0.65% decrease from a year earlier, with the FY2025 full-year figure at $29.8 million, up 12.23% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $29.0 million, down from $29.8 million in the prior quarter.
  • Over the last five years, Non-Current Assets for VRNO reached as high as $95.4 million in Q3 2022 and fell as low as $21.7 million in Q3 2023.
  • Historically, Non-Current Assets has averaged $42.1 million across 5 years, with a median of $29.0 million in 2025.
  • Across the five-year window, Non-Current Assets tumbled 77.28% in 2023 and increased 15.95% in 2024, its largest moves.
  • Year by year, Non-Current Assets stood at $72.1 million in 2022, then tumbled by 60.37% to $28.6 million in 2023, then dropped by 7.05% to $26.6 million in 2024, then increased by 12.23% to $29.8 million in 2025, then declined by 2.63% to $29.0 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $29.0 million in Q1 2026, $29.8 million in Q4 2025, and $28.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Verano Holdings 2.02 Bn 1.94 Bn 98.98 Mn 29.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 29.02 Mn
Dec 31, 2025 29.80 Mn
Sep 30, 2025 28.22 Mn
Jun 30, 2025 28.98 Mn
Mar 31, 2025 29.21 Mn
Dec 31, 2024 26.56 Mn
Sep 30, 2024 25.13 Mn
Jun 30, 2024 26.27 Mn
Mar 31, 2024 26.73 Mn
Dec 31, 2023 28.57 Mn
Sep 30, 2023 21.67 Mn
Jun 30, 2023 81.82 Mn
Mar 31, 2023 82.67 Mn
Dec 31, 2022 72.08 Mn
Sep 30, 2022 95.36 Mn
Dec 31, 2021 207.91 Mn